More News
9 February 2018
Seattle Genetics and Pieris Pharmaceuticals Announce Multi-Program Immuno-Oncology Collaboration8 February 2018
Texas A&M Institute for Regenerative Medicine and Celltex Therapeutics Enter Agreement for Alzheimer’s Research8 February 2018
Fujifilm and Takeda Announce Collaboration to Develop Regenerative Medicine Therapies using Cardiomyocytes Derived from iPSC7 February 2018
Advanced Proteome Therapeutics and ImmunoBiochem Corporation enter into a Collaboration and Option Agreement1 February 2018
Evolve BioSystems Partners With King’s College London to Resolve Gut Dysbiosis in C-Section Delivered Infants1 February 2018
UCB and investor syndicate led by Novo Seeds launch Syndesi Therapeutics to develop novel therapeutics for cognitive disorders31 January 2018
Seattle Genetics to Acquire Cascadian Therapeutics, Adding Late-Stage Breast Cancer Program to Its Oncology Pipeline31 January 2018
BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease29 January 2018
Metrion Biosciences acquires rights to small molecule potassium channel inhibitors from Japan Tobacco Inc.29 January 2018
Sanofi to acquire Ablynx for €3.9 billion25 January 2018
Karyopharm Announces Agreement for Biogen to Acquire KPT-350 for the Treatment of Neurological and Neurodegenerative Conditions25 January 2018
Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders24 January 2018
Bonti Announces Close of $15.5 Million Series C Funding and Appointment of David Ramsay as Chief Financial OfficerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports